News | Ultrasound Imaging | September 15, 2020

Philips Expands Cardiovascular Ultrasound With Affiniti CVx to Increase Productivity

Release 7.0 of Epiq CVx offers breakthrough interventional and productivity features to support cardiology departments managing everyday challenges

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

September 15, 2020 — Philips Healthcare recently introduced the latest addition to its portfolio of dedicated cardiovascular ultrasound solutions, the Affiniti CVx. The system aims to support cardiology departments in delivering better care to more patients with increased efficiency and throughput.

With increasing patient volumes due to higher cardiac disease burden, clinicians are being asked to do more in less time and with fewer resources. The new Affiniti CVx enables a tailored workflow for cardiologists by integrating with a common platform that was first introduced with Epiq CVx, the Philips premium cardiology ultrasound system. Affiniti CVx includes a familiar configurable UI, many popular automated tools and the sharing of transducers, now including TEE transducers, across the Affiniti CVx and Epiq CVx systems. Affiniti CVx will also feature AutoStrain technology, which has been shown to reduce strain analysis time by 70%. Together, these features will enable cardiology departments to standardize their ultrasound fleet for easier management, simplify cross-platform clinician training and reduce the total cost of ownership.

At the European Society of Cardiology (ESC) 2020, Philips debuted its new Affiniti CVx and release 7.0 for Epiq CVx cardiovascular ultrasound solutions, which include improvements to enhance confidence in diagnosis and procedures, as well as improve the user experience.

“The COVID-19 pandemic has created an urgent need for nimble, user-friendly cardiac ultrasound solutions that can keep patients and healthcare providers safe while also generating the data needed to make confident decisions. With Release 7.0 of Epiq CVx and Affiniti CVx, we’ve sharpened our focus on improving the cardiology experience by increasing the integration of our platforms to meet this demand,” said Alexandra Gonçalves, M.D., MMSc, Ph.D., cardiologist and medical officer for cardiology and personal health at Philips. “Taken together, these releases help cardiology teams work faster and with greater precision and efficiency so that they can deliver the best possible heart care.”

For more information: www.philips.com/affiniti-cvx 
 

Increasing Cardiac Diagnostic Confidence With the Epiq CVx

Clinicians are needing to diagnose, plan treatments, monitor or follow up with patients more frequently. Philips Epiq CVx provides a suite of features that can significantly reduce the time spent per patient, whether in the echo lab, at the patient bedside, or during procedures.

Release 7.0 for Epiq CVx and Epiq CVxi continues Philips leadership in interventional echocardiography and will provide new ways to better appreciate morphology, to size devices, and reduce the overall procedure time. 

Industry-first dedicated tools such as 3-D Auto LAA enable faster measurements of the left atrial appendage (LAA) from 3-D increasing procedure efficiency. Cardiac TrueVue Color and Cardiac TrueVue Glass expand on the current Cardiac TrueVue photo realistic rendering by enhancing the visualization of flow, jet origin and morphology increasing clinician confidence.

Updates to the AutoStrain technology are among many additional new features to improve diagnostic confidence. AutoStrain updates will enhance confidence and efficiency in strain measurements while creating a 70% time saving in the acquisition and processing of images. These capabilities build on automated tools for strain and right heart measurements released in 2019, which have proven especially valuable in monitoring heart health in COVID-19 patients.

 
For more information: www.philips.com/esc

Related Content

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

News | Artificial Intelligence | November 12, 2020
November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd.
An injured sonographer can be detrimental to institutions and clinics facing financial strain and lack of workforce readiness due to COVID-19.  
Sponsored Content | Case Study | Ultrasound Imaging | November 12, 2020
There is a high incidence of ultrasound work-related musculoskeletal disorders (WRMSD) among...
Enhanced axial CT (A) shows diffuse pleural thickening (arrow) with a maximum thickness of 3.17 mm. US image for the corresponding lesion on CT (B) shows diffuse pleural thickening (arrowheads) with a maximum thickness of 3.25 mm. The needle pathway length, measured as the needle length through the pleural lesion, was 6.54 mm (asterisk). Pleural puncture angle (exact value not indicated) is depicted as the angle between the outer line of the pleura and the biopsy needle (thin arrow).

Enhanced axial CT (A) shows diffuse pleural thickening (arrow) with a maximum thickness of 3.17 mm. US image for the corresponding lesion on CT (B) shows diffuse pleural thickening (arrowheads) with a maximum thickness of 3.25 mm. The needle pathway length, measured as the needle length through the pleural lesion, was 6.54 mm (asterisk). Pleural puncture angle (exact value not indicated) is depicted as the angle between the outer line of the pleura and the biopsy needle (thin arrow).

News | Ultrasound Imaging | November 09, 2020
November 9, 2020 — According to an
Honoring essential healthcareprofessionals, Nov. 8-14
News | Radiology Imaging | November 09, 2020
November 9, 2020 — As COVID-19 continues to spre
Images show examples of false-positive aneurysms, including (a) bony structures and vessel bifurcation, (b) veins, (c) vessel curvatures, and (d) calcified plaques. Red box (d) indicates aneurysms annotated by radiologists, and the blue boxes indicate aneurysm candidates provided by the algorithm. Images courtesy of the Radiological Society of North America

Images show examples of false-positive aneurysms, including (a) bony structures and vessel bifurcation, (b) veins, (c) vessel curvatures, and (d) calcified plaques. Red box (d) indicates aneurysms annotated by radiologists, and the blue boxes indicate aneurysm candidates provided by the algorithm. Images courtesy of the Radiological Society of North America

News | Artificial Intelligence | November 04, 2020
November 4, 2020 — A powerful type of ar...
Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)

Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)

News | Ultrasound Imaging | November 02, 2020
November 2, 2020 — Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the
Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

Murray Rebner, M.D., performing a breast ultrasound. Image courtesy of Beaumont Health

News | Breast Imaging | November 02, 2020
November 2, 2020 — Though Black women get ...